+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Levemir"

LEVEMIR Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LEVEMIR Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
From
From
Insulin Intelligence Center 2012-2023 - Product Thumbnail Image

Insulin Intelligence Center 2012-2023

  • Report
  • May 2024
  • Global
From
Diabetes Drug Intelligence Center 2012-2023 - Product Thumbnail Image

Diabetes Drug Intelligence Center 2012-2023

  • Report
  • May 2024
  • Global
From
From
Human Insulin Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Human Insulin Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 144 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
Loading Indicator

Levemir is a medication used to treat endocrine and metabolic disorders, such as diabetes. It is a long-acting insulin analog, meaning it is a synthetic form of insulin that is designed to mimic the body's natural insulin production. Levemir is used to control blood sugar levels in people with type 1 and type 2 diabetes. It is typically taken once or twice daily, depending on the individual's needs. Levemir is available in both vials and pens, and is typically injected under the skin. Levemir is a popular medication for treating endocrine and metabolic disorders, and is widely available in many countries. It is manufactured by Novo Nordisk, a Danish pharmaceutical company, and is available in both generic and branded forms. Other companies that produce Levemir include Sanofi, Eli Lilly, and Biocon. Show Less Read more